Shares of Adient plc (NYSE:ADNT – Get Free Report) reached a new 52-week low during trading on Monday . The stock traded as low as $15.71 and last traded at $16.36, with a volume of 262239 shares trading hands. The stock had previously closed at $17.43.
Analyst Ratings Changes
ADNT has been the subject of several recent research reports. StockNews.com cut shares of Adient from a “buy” rating to a “hold” rating in a report on Wednesday, January 22nd. UBS Group lifted their price target on Adient from $19.00 to $20.00 and gave the company a “neutral” rating in a research note on Wednesday, January 29th. Barclays reduced their price objective on shares of Adient from $24.00 to $21.00 and set an “equal weight” rating for the company in a research report on Wednesday, January 22nd. Bank of America downgraded Adient from a “buy” rating to a “neutral” rating and decreased their target price for the company from $30.00 to $24.00 in a research report on Thursday, November 21st. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Adient from $24.00 to $21.00 and set a “neutral” rating for the company in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating and nine have given a hold rating to the company. According to MarketBeat.com, Adient presently has an average rating of “Hold” and a consensus target price of $21.88.
Read Our Latest Report on Adient
Adient Stock Performance
Adient (NYSE:ADNT – Get Free Report) last posted its quarterly earnings results on Tuesday, January 28th. The company reported $0.27 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.05). Adient had a positive return on equity of 6.94% and a negative net margin of 0.01%. During the same quarter last year, the company posted $0.31 earnings per share. As a group, research analysts anticipate that Adient plc will post 1.89 earnings per share for the current year.
Insider Activity
In other Adient news, EVP James Conklin sold 11,500 shares of Adient stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $20.25, for a total value of $232,875.00. Following the transaction, the executive vice president now directly owns 51,829 shares in the company, valued at approximately $1,049,537.25. This trade represents a 18.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.72% of the company’s stock.
Hedge Funds Weigh In On Adient
Several institutional investors have recently bought and sold shares of the company. Versant Capital Management Inc boosted its holdings in Adient by 10,316.7% during the fourth quarter. Versant Capital Management Inc now owns 1,875 shares of the company’s stock worth $32,000 after buying an additional 1,857 shares in the last quarter. R Squared Ltd acquired a new stake in shares of Adient during the 4th quarter valued at approximately $32,000. US Bancorp DE grew its holdings in shares of Adient by 583.8% in the 3rd quarter. US Bancorp DE now owns 1,860 shares of the company’s stock worth $42,000 after acquiring an additional 1,588 shares during the period. Signaturefd LLC increased its stake in Adient by 493.8% in the 3rd quarter. Signaturefd LLC now owns 2,191 shares of the company’s stock valued at $49,000 after purchasing an additional 1,822 shares in the last quarter. Finally, KBC Group NV increased its stake in Adient by 51.8% in the 3rd quarter. KBC Group NV now owns 3,328 shares of the company’s stock valued at $75,000 after purchasing an additional 1,136 shares in the last quarter. 92.44% of the stock is owned by institutional investors and hedge funds.
Adient Company Profile
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
See Also
- Five stocks we like better than Adient
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now
- Canada Bond Market Holiday: How to Invest and Trade
- Big Dividend Hikes: 4 Large-Cap Stocks Increasing Payouts
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Procter & Gamble: A Consumer Staples Titan Built to Win
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.